Sen. Amy Klobuchar, one of the most senior Democrats eligible to replace Sen. Bob Menendez, D-N.J., on the Finance Committee is not interested in pursuing the seat, according to a source familiar with her thinking. Menendez on Tuesday informed Gov. Phil Murphy, D-N.J., and his Senate colleagues that he would resign from the chamber next month
While most of the attention has been on former President Donald Trump and the GOP as the Republican National Convention takes place in Milwaukee, President Joe Biden and other Democrats have touted policy wins like building bridges and efforts to address housing costs. The Biden administration on Thursday announced $5 billion for major bridge construction
Other healthcare companies such as Daiichi Sankyo have also announced investments in Germany recently, in a positive sign for the ruling coalition government. ADVERTISEMENT French pharmaceutical giant Sanofi could potentially invest somewhere between €1.3 billion and €1.5 billion in its Frankfurt manufacturing site making the insulin brand, Lantus, according to German newspaper Handelsblatt and Reuters.
Senate Finance Chair Ron Wyden said committee Democrats left a meeting on next year’s tax battle aligned on the need for wealthy individuals and multinational corporations to pay more in taxes. Wyden, D-Ore., said he would work with other Democrats on the panel to come up with a “menu” of possible revenue raisers, as preparations
Pharma Investing Is All About Service Now. The Patent-Cliff Era Is Ending.
About the author: Molly McGaughan is managing director for North America at Beyond. For decades, investors have chosen pharma stocks based largely on which companies have drugs and vaccines being sold to large numbers of people. Savvy shareholders in these companies have worked to avoid looming “patent cliffs”—the moments when exclusivity on popular therapies runs